Promising Data Supports Curcumin Treatment for Mesothelioma

The plant-based substance curcumin could soon be included in the multidisciplinary treatment of malignant mesothelioma, according to a recent multicenter, international study review. Curcumin, an active compound found in the common culinary spice turmeric, has been used for decades by some as an anti-inflammatory, complementary medicine for many ailments. It may soon take a more prominent role with mesothelioma, an aggressive cancer with no definitive cure. “Our hope is that, in the not-too-distant future, it could be part of new therapeutic strategies for mesothelioma,” Dr. Antonio Giordano, director of Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, told The Mesothelioma Center at Asbestos.com. The International Journal of Molecular Sciences published the review on March 7. Dr. Alfonso Baldi, professor at the University of Campania in Caserta, Italy, was the lead author. Giordano was one of four co-authors. Seven Recent Curcumin Studies Reviewed The review included the work of seven different studies in recent years that looked at the use of curcumin with mesothelioma tumor cells in various in vivo or in vitro models. Key Takeaways from the Curcumin Review Intraperitoneal administration of curcumin increased survival of mice and reduced the risk of developing tumors. Intracavity administration of curcumin significantly decreased tumor mass in the sarcomatoid subtype, inducing abundant necrosis (tumor cell deat...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news